May 14th, 2012
•Generation of T lymphocytes from induced pluripotent stem (iPS) cells gives an alternative approach of using embryonic stem cells for T cell-based immunotherapy. The method shows that by utilizing either in vitro or in vivo induction system, iPS cells are able to differentiate into both conventional and antigen-specific T lymphocytes.
Tags
Related Videos
Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes
Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells
Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation
Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
Derivation of T Cells In Vitro from Mouse Embryonic Stem Cells
In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol
Rapid Quantification of Mitogen-induced Blastogenesis in T Lymphocytes for Identifying Immunomodulatory Drugs
An In Vivo Mouse Model to Measure Naïve CD4 T Cell Activation, Proliferation and Th1 Differentiation Induced by Bone Marrow-derived Dendritic Cells
Induced Differentiation of M Cell-like Cells in Human Stem Cell-derived Ileal Enteroid Monolayers
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved